L, Z.H.W, N.Y.C, and
30600238 for L.Z, S.H.L, Q.R), and the projects from Tianjin Municipal Science and Technology Commission(06YFSZSF01300 for B.L, selleckchem L.Z, H.Z, and 07JCYBJC11200 for L.Z, B.L).We thank the EasyStar company http://essaystar.com/ for their excellent English language editing. References 1. Goulden N, Langlands K, Steward C, Katz F, Potter M, Chessells J, Oakhill A: PCR assessment of bone marrow status in “”isolated”" extramedullary relapse of childhood B-pre-cursor acute lymphoblastic leukemia. Br J Hematol 1994, 87: 282–5.CrossRef 2. Song X, Liu X, Chi W, Liu Y, Wei L, Wang X, Yu J: Hypoxia-Evofosfamide purchase induced resistance to cisplatin and doxorubicin in nonsmall cell lung cancer is inhibited by silencing of HIF-1α gene. Cancer Chemotherapy and Pharmacology 2006, 58: 776–84.CrossRefPubMed 3. Gibson LF: Survival of B lineage leukemic cells: signals from the bone marrow microenvironment. Leuk Lymphoma 2002, 43: 19–27.CrossRefPubMed 4. Tabe Y, Jin L, Tsutsumi-Ishii Y, Xu Y, McQueen T, Priebe W, Mills GB, Ohsaka A, Nagaoka I, Andreeff M, Konopleva M: Activation of integrin-linked kinase is a critical prosurvival pathway induced in
leukemic cells by bone marrow-derived stromal cells. Cancer Res 2007, 67: 684–94.CrossRefPubMed https://www.selleckchem.com/products/blasticidin-s-hcl.html 5. Wang L, Fortney JE, Gibson LF: Stromal cell protection of B-lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt. Leuk Res 2004, 28: 733–42.CrossRefPubMed 6. Konopleva M, Konoplev S, Hu W, Zaritskey AY, Afanasiev BV, Andreeff M: Stromal tetracosactide cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia 2002, 16: 1713–24.CrossRefPubMed 7. Xu Q, Simpson SE, Scialla TJ, Bagg A, Carroll M: Survival of acute myeloid leukemia cells requires PI3-kinase activation. Blood 2003, 102: 972–80.CrossRefPubMed 8. Kubota Y, Ohnishi H, Kitanaka A, Ishida T, Tanaka T: Constitutive activation of PI3K is involved in the spontaneous
proliferation of primary acute myeloid leukemia cells:direct evidence of PI3K activation. Leukemia 2004, 18: 1438–40.CrossRefPubMed 9. Min YH, Eom JI, Cheong JW, Maeng HO, Kim JY, Jeung HK, Lee ST, Lee MH, Hahn JS, Ko YW: Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable. Leukemia 2003, 17: 995–7.CrossRefPubMed 10. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8: 315–7.CrossRefPubMed 11. Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D, Dazzi F: Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 2007, 21: 304–10.CrossRefPubMed 12.